BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wagner AD, Grothey A, Andre T, Dixon JG, Wolmark N, Haller DG, Allegra CJ, de Gramont A, VanCutsem E, Alberts SR, George TJ, O'Connell MJ, Twelves C, Taieb J, Saltz LB, Blanke CD, Francini E, Kerr R, Yothers G, Seitz JF, Marsoni S, Goldberg RM, Shi Q. Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database. J Natl Cancer Inst 2021;113:400-7. [PMID: 32835356 DOI: 10.1093/jnci/djaa124] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Gallois C, Shi Q, Meyers JP, Iveson T, Alberts SR, de Gramont A, Sobrero AF, Haller DG, Oki E, Shields AF, Goldberg RM, Kerr R, Lonardi S, Yothers G, Kelly C, Boukovinas I, Labianca R, Sinicrope FA, Souglakos I, Yoshino T, Meyerhardt JA, André T, Papamichael D, Taieb J. Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials. J Clin Oncol 2023;41:803-15. [PMID: 36306483 DOI: 10.1200/JCO.21.02726] [Reference Citation Analysis]
2 Rakshith HT, Lohita S, Rebello AP, Goudanavar PS, Raghavendra Naveen N. Sex differences in drug effects and/or toxicity in oncology. Curr Res Pharmacol Drug Discov 2023;4:100152. [PMID: 36714036 DOI: 10.1016/j.crphar.2022.100152] [Reference Citation Analysis]
3 Luo D, Eicher M, White K. Resilience in adults with colorectal cancer: Refining a conceptual model using a descriptive qualitative approach. J Adv Nurs 2022. [PMID: 36239211 DOI: 10.1111/jan.15464] [Reference Citation Analysis]
4 Chen S, Cao X, Ben S, Zhu L, Gu D, Wu Y, Li S, Yu Q. Genetic variants in RNA m(5) C modification genes associated with survival and chemotherapy efficacy of colorectal cancer. Cancer Med 2023;12:1376-88. [PMID: 35861369 DOI: 10.1002/cam4.5018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang H, Jia H, Gao Y, Zhang H, Fan J, Zhang L, Ren F, Yin Y, Cai Y, Zhu J, Zhu ZJ. Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nat Commun 2022;13:7802. [PMID: 36528604 DOI: 10.1038/s41467-022-35511-y] [Reference Citation Analysis]
6 Cabañero D, Villalba-Riquelme E, Fernández-Ballester G, Fernández-Carvajal A, Ferrer-Montiel A. ThermoTRP channels in pain sexual dimorphism: new insights for drug intervention. Pharmacol Ther 2022;240:108297. [PMID: 36202261 DOI: 10.1016/j.pharmthera.2022.108297] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang S, Li T, Wang Y, Wang M, Liu Y, Zhang X, Zhang L. 5-Fluorouracil and actinomycin D lead to erythema multiforme drug eruption in chemotherapy of invasive mole: Case report and literature review. Medicine (Baltimore) 2022;101:e31678. [PMID: 36451432 DOI: 10.1097/MD.0000000000031678] [Reference Citation Analysis]
8 Margalit O, Harmsen WS, Shacham-shmueli E, Voss MM, Boursi B, Wagner AD, Cohen R, Olswold CL, Saltz LB, Goldstein DA, Hurwitz H, Tebbutt NC, Kabbinavar FF, Adams RA, Chibaudel B, Grothey A, Yoshino T, Zalcberg J, de Gramont A, Shi Q, Lenz H. Evaluating Sex as a Predictive Marker for Response to Bevacizumab in Metastatic Colorectal Carcinoma: Pooled Analysis of 3,369 Patients in the ARCAD Database. European Journal of Cancer 2022. [DOI: 10.1016/j.ejca.2022.10.022] [Reference Citation Analysis]
9 Xu Y, He X, Wang Y, Jian J, Peng X, Zhou L, Kang Y, Wang T. 5-Fluorouracil reduces the fibrotic scar via inhibiting matrix metalloproteinase 9 and stabilizing microtubules after spinal cord injury. CNS Neurosci Ther 2022. [PMID: 35918897 DOI: 10.1111/cns.13930] [Reference Citation Analysis]
10 Papachristos A, Ratain MJ. Lurbinectedin-induced thrombocytopenia: the role of body surface area. Cancer Chemother Pharmacol 2022. [PMID: 35362793 DOI: 10.1007/s00280-022-04422-6] [Reference Citation Analysis]
11 Duarte SS, Silva DKF, Lisboa TMH, Gouveia RG, de Andrade CCN, de Sousa VM, Ferreira RC, de Moura RO, Gomes JNS, da Silva PM, de Lourdes Assunção Araújo de Azevedo F, Keesen TSL, Gonçalves JCR, Batista LM, Sobral MV. Apoptotic and antioxidant effects in HCT-116 colorectal carcinoma cells by a spiro-acridine compound, AMTAC-06. Pharmacol Rep 2022. [PMID: 35297003 DOI: 10.1007/s43440-022-00357-0] [Reference Citation Analysis]
12 Zinter MS, Versluys AB, Lindemans CA, Mayday MY, Reyes G, Sunshine S, Chan M, Fiorino EK, Cancio M, Prevaes S, Sirota M, Matthay MA, Kharbanda S, Dvorak CC, Boelens JJ, DeRisi JL. Pulmonary microbiome and gene expression signatures differentiate lung function in pediatric hematopoietic cell transplant candidates. Sci Transl Med 2022;14:eabm8646. [PMID: 35263147 DOI: 10.1126/scitranslmed.abm8646] [Reference Citation Analysis]
13 Sabry NM, Naguib TM, Kabel AM, Khafagy E, Arab HH, Almorsy WA. Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients’ Survival: A Randomized Controlled Trial. Medicina 2022;58:394. [DOI: 10.3390/medicina58030394] [Reference Citation Analysis]
14 De Francia S, Berchialla P, Armando T, Storto S, Allegra S, Sciannameo V, Soave G, Sprio AE, Racca S, Caiaffa MR, Ciuffreda L, Mussa MV. Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities? Eur J Clin Pharmacol 2022. [PMID: 35192004 DOI: 10.1007/s00228-022-03298-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Özdemir B, Oertelt-prigione S, Adjei A, Borchmann S, Haanen J, Letsch A, Mir O, Quaas A, Verhoeven R, Wagner A. Investigation of sex and gender differences in oncology gains momentum: ESMO announces the launch of a Gender Medicine Task Force. Annals of Oncology 2022. [DOI: 10.1016/j.annonc.2021.11.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 García-Alfonso P, Saiz-Rodríguez M, Mondéjar R, Salazar J, Páez D, Borobia AM, Safont MJ, García-García I, Colomer R, García-González X, Herrero MJ, López-Fernández LA, Abad-Santos F. Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines. Clin Transl Oncol 2021. [PMID: 34773566 DOI: 10.1007/s12094-021-02708-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Zinter MS, Versluys BA, Lindemans CA, Mayday MY, Reyes G, Sunshine S, Chan M, Fiorino E, Cancio M, Prevaes S, Sirota M, Matthay MA, Kharbanda S, Dvorak CC, Boelens JJ, Derisi JL. Metatranscriptomic Signatures of Lung Function in Pediatric Hematopoietic Cell Transplant Candidates.. [DOI: 10.1101/2021.09.21.21263910] [Reference Citation Analysis]
18 Zheng NS, Wang F, Agarwal R, Carroll RJ, Wei WQ, Berlin J, Shu XO. Racial disparity in taxane-induced neutropenia among cancer patients. Cancer Med 2021;10:6767-76. [PMID: 34547180 DOI: 10.1002/cam4.4181] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Mathew A, Tirkey AJ, Li H, Steffen A, Lockwood MB, Patil CL, Doorenbos AZ. Symptom Clusters in Head and Neck Cancer: A Systematic Review and Conceptual Model. Semin Oncol Nurs 2021;37:151215. [PMID: 34483015 DOI: 10.1016/j.soncn.2021.151215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Villalvazo P, Marzal-Alfaro B, García-Alfonso P, Revuelta-Herrero JL, Thomas F, López-Tarruella S, García-González X, Calvo A, Yakoubi M, Salvador-Martín S, López-López F, Aguilar I, Sanjurjo-Sáez M, Martín M, López-Fernández LA. DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach. J Pers Med 2021;11:792. [PMID: 34442436 DOI: 10.3390/jpm11080792] [Reference Citation Analysis]
21 Drami I, Pring ET, Gould L, Malietzis G, Naghibi M, Athanasiou T, Glynne-Jones R, Jenkins JT. Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing? Clin Oncol (R Coll Radiol) 2021:S0936-6555(21)00188-6. [PMID: 34147322 DOI: 10.1016/j.clon.2021.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
22 Boland PM, Hochster HS. Making Fluorouracil "Sexy" Again. J Natl Cancer Inst 2021;113:351-2. [PMID: 32835362 DOI: 10.1093/jnci/djaa125] [Reference Citation Analysis]
23 Mauvais-Jarvis F, Berthold HK, Campesi I, Carrero JJ, Dakal S, Franconi F, Gouni-Berthold I, Heiman ML, Kautzky-Willer A, Klein SL, Murphy A, Regitz-Zagrosek V, Reue K, Rubin JB. Sex- and Gender-Based Pharmacological Response to Drugs. Pharmacol Rev 2021;73:730-62. [PMID: 33653873 DOI: 10.1124/pharmrev.120.000206] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 19.0] [Reference Citation Analysis]
24 Roberto M, Rossi A, Panebianco M, Pomes LM, Arrivi G, Ierinò D, Simmaco M, Marchetti P, Mazzuca F. Drug-Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN® System Comprehensive Approach. Pharmaceuticals (Basel) 2021;14:67. [PMID: 33467633 DOI: 10.3390/ph14010067] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
25 Mendis S, Anand S, Karasinska JM, Dasari A, Unger JM, Gothwal A, Ellis LM, Varadhachary G, Kopetz S, Overman MJ, Raghav K, Loree JM. Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies. Oncologist 2021;26:107-14. [PMID: 32960478 DOI: 10.1002/onco.13534] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
26 Fluoropyrimidine-related AEs greater in women. Reactions Weekly 2020;1820:7-7. [DOI: 10.1007/s40278-020-82827-x] [Reference Citation Analysis]